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As MIR prepares for its 60th anniversary reunion in 1991, the 1966-1967 residents and fellows
will join in the celebration for their 25th anniversary. Seated, left to right, are Doctors William
Miller; Richard Irackler; Juan Taveras, director of the Institute from 1964 to 1971; Hugh M.
Wilson, director of the Institute from 1949 to 1963; William Mill; and Robert Hurley. Middle
row, left to right, are Doctors C. Jay Kees; Katherine Jacobs; John Bardsley, presently on staff
as assistant professor of clinical radiology; Gerald Shaikun, presently on staff as instructor
in clinical radiology; Charles Williams; and Allan McCown, presently on staff as assistant
professor of clinical radiology. Back row, left to right, are Doctors Myo Kyaw, John Fenlon,
James Debnam, andEmilio Torres-Reyes. Photograph courtesy of the Office of the Director—
Mallinckrodt Institute of Radiology.
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AND BABY MAKES THREE
An interventional radiology procedure called selective ostial salpingography and
recanalization is making dreams come true for some of the 3.5 million infertile
couples in the U.S.
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BREATHING EASY
Surgeons and radiologists are collaborating in a study that promises to detect
early rejection of lung transplants in emphysema patients.
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JOINT EFFORT
Magnetic resonance imaging has become the procedure of choice for diagnosing
sports injuries to the joints.
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On March 21, 1988, Connie Pisetta became the first patient at MIR to undergo selective
ostial salpingography. Brenden is the happy result.
Photograph by Cliff Willis.
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SPOT NEWS
Raichle 1990
Recipient of
Aebersold
Award
The Society of Nuclear
Medicine (SNM) annually
presents the prestigious
Aebersold Award to that
researcher whose work has
produced outstanding
achievements in the field
of nuclear medicine while
promoting a widespread
appreciation of the scientific value of nuclear medicine through basic and
clinical research. Marcus
Raichle, M.D., professor of
radiology and neurology, was
the logical and deserving
choice for this year's honor,
which was presented at the
Society's 36th Annual
Meeting held in June.
For the past two decades,
Raichle has focused his
attention and efforts on
the study of the human
brain. Using the tools of
nuclear medicine, especially cyclotron-produced
short-lived radionuclides
and positron emission
tomography (PET), Raichle's
studies of cerebral blood
flow and metabolism have
provided a sound scientific
foundation on which other
researchers can build.
Raichle began using
positron-emitting cyclotronproduced radionuclides
coupled with angiography
for studies of human and
other primate brains as far
back as 1971, at a time
when other neurosciences
researchers were not familiar
with the tracers. His desire
to find a less invasive
method of studying the
brain led Raichle to PET
and the development of
methods for the measurement of regional cerebral
blood flow and metabolism;
methods that to this day
are regarded as the only

Marcus Raichle, M.D., is a
pioneer in the field of
cerebral blood flow and
metabolism.
procedure to use.
Within the past 10
years, Raichle's work has
focused on the application
of PET to the study of psychiatric disorders and
developing functional maps
of the areas of the brain
involved in sensory and
language information
processing.

Breast Cancer
Recurrence Rate
Lowered by
Brachytherapy
Robert R. Kuske, M.D.,
assistant professor of radiology and chief of breast
service in Radiation Oncology, had some good news to
share at the Second International Brachytherapy
and Remote Afterloading
Symposium held April
19-21 in St. Louis.
In his study involving
417 women with breast
cancer who were followed
a minimum of five years after
treatment and half of whom
received radiation breast
implants (brachytherapy),
Kuske reported a low 4.6

percent recurrence of
breast cancer—one of the
lowest figures reported in
medical literature.
According to statistics
from the American Cancer
Society (ACS), more than
1,000 women in Missouri will
die from breast cancer in
1990. The Department of
Health also had a startling
prediction for Missouri—
3,200 new cases of breast
cancer will be diagnosed
this year. With the increasing incidence of breast
cancer and the public's
increased awareness of the
disease, more women now
are aware of the various
treatment options. Many
patients are choosing lumpectomy (removing only the
malignant lump plus a margin of surrounding tissue)
followed by radiation.
Some of these women will
have radiation implants
placed in the affected
breast in addition to standard external radiotherapy.
It is this group of women in
whom the recurrence rates
have been lowered so
drastically.
According to Kuske,
"Brachytherapy shortens
the overall treatment time
because the implant gives
two weeks worth of radiation in two days. This treatment option gives a higher
dose of radiation and it's
concentrated on the area
of the breast at highest
risk. We can also target
large tumors that are
located deep in the breast
tissue."

MALLINCKRODT INSTITUTE OF RADIOLOGY
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SPOT NEWS
McClennan
Named FDA
Consultant
Bruce L. McClennan,
M.D., professor of radiology,
has been appointed a consultant to the Center for
Drug Evaluation and
Research by the Food and
Drug Administration (FDA).
The Center reviews and
approves all U.S. prescription drugs and monitors the
quality of marketed drug
products as well as conducts research and develops
scientific standards on the
quality, safety and effectiveness of drugs for
human use.
McClennan, a nationally
recognized expert in the
field of genitourinary radiological research and in the
assessment of radioiodinated
contrast agents, will advise
the Center on the safety
and efficacy of substances
proposed for use in the
treatment or diagnosis of
diseases and illnesses.

Winthrop
Award Goes to
Mirowitz
A team of researchers
led by Scott A. Mirowitz,
M.D., instructor of radiology, has developed a technique for magnetic
resonance imaging of the
upper abdominal area. The
results of their research
was published in the April,
1990 issue of the journal,
Radiology, and was placed
into competition at the
annual meeting of the
Society of Computed Body
Tomography held recently
in Palm Springs, California.
From more than 20
papers presented for the
competition, Mirowitz, along
with Joseph K. T. Lee,
FOCAL SPOT, SUMMER, 1990

M.D.; Jeffrey J. Brown,
M.D.; Steven S. Eilenberg,
M.D.; Jay P. Heiken, M.D.;
and William Perman, Ph.D.,
received one of three major
awards—the prestigious
Winthrop Award, which
carries a $10,000 grant for
further research.
Called rapid acquisition
spin-echo (RASE), the technique produces images that
are free of respiratoryinduced blurring while
allowing for dynamic contrast material-enhanced
scanning of the entire liver
using the contrast agent,
gadolinium. The study, the
Ronald G. Evens, M.D.,
only one of its kind in the
director of the Institute,
United States, involved the
greeted the members of
imaging of various organs
Greater Missouri: Focus on
in 100 patients who each
Leadership. This diverse
had to hold his breath for
group ofprofessional women
believes that effective leader23 seconds, which is well
ship calls for knowledge as
within the breath-holding
well as commitment. Evens
capability of most patients,
talked about the health-care
while a contrast agent was
administered intravenously. dilemma our society faces:
According to Mirowitz,
'Although previous studies
have demonstrated superior
sensitivity of magnetic
resonance imaging compared
to computed tomography in
detecting liver lesions,
Joseph L. Roti Roti,
implementation of MR for
scanning the upper abdomen Ph.D., professor of radiology and chief of the cancer
has been met with several
biology section, has been
obstacles. Foremost among
these obstacles are the long elected to a three-year
term for the office of
acquisition times and the
degrading effects of physio- councilor-at-large of the
Radiation Research Society
logic motion, such as
breathing, on the MR image." in recognition of his contributions to cancer biology
This breath-holding techresearch, his work in the
nique will improve the
measurement of molecular
quality of MR images as
changes in cancer cells'
well as reduce imaging
response to heat and radiatimes for claustrophobic
tion, and his development
patients or those with
of mathematical tools
other conditions that limit
measuring the effects of
tolerance of extended
radiation and heat. Roti Roti's
imaging times.
research has centered on
the mechanisms of cell
response to radiation,
chemotherapy, and hyper-

Roti Roti
Elected to
Office

how to make a shrinking
budget cover costlier health
care. "The answer ultimately lies with you; you
will have to decide what you
are willing to forgo in the
way of medical technology.
We can't have it all,"
explained Evens to more
than 60 attendees.

thermia with emphasis on
cell kinetics and nuclear
targets.
As one of 10 members
serving in this capacity,
Roti Roti will assist in
policy recommendations and
changes and committee
reports as well as voting on
issues and bylaws.
An international
organization of over 2,000
scientists, the 38-year-old
Radiation Research Society
encourages the advancement of radiation research
in all areas of the natural
sciences while promoting
the dissemination of
knowledge.
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(left to right) William J.
Hoskins, M.D., speaker for
the 1990 Probstein Oncology
Lecture and an advocate for
the development ofa screening
method for ovarian cancer,
was citedfor his contributions
to clinical oncology by Carlos
A. Perez, M.D., director of
the Radiation Oncology
Center.

Ovarian
Cancer: The
Silent Killer
William J. Hoskins, M.D.,
guest speaker for the annual
Probstein Oncology Lecture,
had some disturbing statistics to share with his
audience: more than 20,000
women in the United States
will be diagnosed with
ovarian cancer (attributed
to 29 percent of cancers in
women), and 53 percent of
those women will die as a
result of the disease.
The cause of ovarian
cancer is unknown; there is
no screening examination
as there is the Pap smear
for cervical cancer or the
mammogram for breast
cancer. Called "the silent
killer," ovarian cancer
usually demonstrates no
signs or symptoms until the

disease is in an advanced
stage. This cancer tends to
spread quickly throughout
the abdominal area, often
involving lymph glands, the
liver, or the lungs.
Hoskins, associate chief
of the gynecology service
at Memorial Sloan-Kettering
Cancer Center and associate
professor of obstetrics/
gynecology at Cornell University Medical Center in
New York, pointed out in
his talk, "Ovarian Cancer:
Current Treatment and
Future Perspective," that
there is a bright spot in the
fight against this disease.
The National Cancer Institute has formed a task
force to establish some

method of screening for
ovarian cancer. Research
into the staging of this
cancer holds great promise.
In one of Hoskins'
studies involving 67
patients, 25 percent of
those women whose cancer
had been detected and
then had undergone surgery had tumors remaining
after surgery.
"The importance of
surgical evaluation of the
entire tumor area and its
staging is critical in the
second look. The less
tumor remaining at the end
of surgery, the better the
survival rate," said
Hoskins.
According to Hoskins,
chemotherapy will play a
major role in defeating
ovarian cancer. Patients
will have a 50 percent
chance of survival if
tumors remaining after surgery are detected and if
surgery is followed by
chemotherapy.
"A very intensive
chemotherapy treatment
plan, a high dose administered intravenously, may be
effective," he said.

Welch's
Research Earns
American
Chemical
Society Honors
In the 23 years since
Michael J. Welch, Ph.D.,
professor of radiation
chemistry, first joined the
MIR staff, his contributions
in the field of radiopharmaceutical chemistry have
been many. His work,
focusing on the labeling of
chemical compounds with
short-lived radionuclides, is
cited worldwide, and the
compounds developed by
Welch and his research
team are used for medical
research and diagnosis
throughout the world.
In recognition of his
achievements, the more
than 30,000 members of
the American Chemical
Society (ACS) selected
Welch as recipient of the
prestigious ACS Award for
Nuclear Chemistry. The
presentation was made in
April at the 199th ACS
National Meeting in Boston.

MALLINCKRODT INSTITUTE OF RADIOLOGY
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Royal Assesses
Effects of
Chernobyl
Henry D. Royal, M.D.,
associate professor of radiology and associate director
of Nuclear Medicine, was
one of two U.S. physicians
invited to participate in an
in-depth study of illnesses
attributed to the 1986
nuclear reactor explosion
in Chernobyl. Prompted by
a request from the International Atomic Energy
Agency (IAEA) and the
Soviet government, Royal,
who serves on the IAEA's
medical effects team,
reviewed data collected by
Soviet scientists regarding
the effects of the nuclear
accident.
The IAEA includes
representatives from 113
countries who are considered
experts in the fields of
radiation protection, medicine, epidemiology, radioecology and psychology.
The medical effects team
analyzed the clinical health
effects from radiation
exposure and evaluated the
general health situation in
the areas of corroboration
of bioassay and biological
dosimetry, blood disorders,
immune function, lead toxicity, neoplasms, thyroid
disease, the effects on
pregnancy and birth rate,
nutrition analysis, cataracts,
and stress effects.
The government and
the people of the Soviet
Union are concerned about
the radiological conse-
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quences from the nuclear
accident as well as the
impact of living in contaminated areas. "The people
are our main concern," said
Royal. "Although a complete assessment of the
effects of the accident will
take many years, the presence of an independent
team of international experts
hopefully will alleviate
some of the anxiety of the
Soviet people."
The medical effects
team will make a second
visit in the fall of 1990 to
perform its own health survey, examining the people
from contaminated and
noncontaminated villages
to determine the incidence
of potential radiationrelated illnesses.

Dual Honors
for Wilson
Award
For the fourth consecutive year, the presentation
of the Hugh M. Wilson
Award was made to two
graduating medical students who made meritorious contributions to the
Department of Radiology.
The 1990 recipients are
Paul L. Chesis, M.D., Ph.D.,
and Christopher M.
Speidel, M.D.
According to Fernando
R. Gutierrez, M.D., associate professor of radiology,
who assisted in reviewing
the nominations, "Each
year the continuous high
quality of the nominees
causes the selection
process to become more
and more difficult. This
year's nominees have made
significant contributions
with their work at the
Institute.''
Chesis, who completed
his Ph.D. studies while
working with Michael J.

According to Ernest L.
Wynder, M.D., president and
founder of the American
Health Foundation and keynote speaker for the 1990
Freund Lecture, "Thefunction of medicine is to help
people die young as late in
life as possible." Wynder's

lecture, "Cancer Prevention
and the Role of Nutrition,"
highlighted the correlation
between lung cancer and
smoking and dietary fat.
Carlos A. Perez, M.D., (right)
honored Wynder for his
meritorious research in
clinical oncology.

Welch, Ph.D., professor of
radiation chemistry, conducted research on the
synthesis and characterization of positron emitting
ligands for the opioid
receptor system. His work
has resulted in four publications (one in the Journal
of Nuclear Medicine and
three in press) as well as five
presentations at the Society
of Nuclear Medicine meeting in June.
In his work with
Michael W. Vannier, M.D.,
professor of radiology and
director of the image
processing lab, Speidel

implemented a comprehensive computerized database
consisting of thousands of
examination records.
"Speidel's research in the
area of multispectral magnetic resonance image
analysis is very important
in our laboratory," said
Vannier.
Chesis and Speidel were
officially presented with the
Wilson Award, which
honors former Mallinckrodt
Institute Director Hugh M.
Wilson, by Ronald G.
Evens, M.D., director of the
Institute, at the Annual
Senior Awards night in May.
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o matter what
room you are in, the cozy home of
Jim and Connie Pisetta in suburban
St. Louis conveys a distinct message: A baby lives here. Playpen in
the living room. Pediatrician's
phone number on a kitchen blackboard. Baby pictures on the
refrigerator door. Stenciled teddy
bears in a small bedroom belonging
to eight-month-old Brenden.
But as the plump child sleeps in
his mother's arms, Connie Pisetta
recalls a time when this scene was
only a dream. Before Brenden was
conceived, she and Jim had waged
a war against their infertility—in
their case, caused by an obstruction
in Connie's Fallopian tubes. Riding
an emotional roller coaster of hope
and despair, Connie eventually
stopped going to the baby showers
of friends and relatives.
"I was happy they could have
a baby," says Connie, 33, "but it just
reminded me of something I really
wanted and couldn't have."
By Robert Lowes
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hanks to an innovative, twostep procedure for infertile
women, available through
the Mallinckrodt Institute of
Radiology (MIR) and Barnes
Hospital at the Washington
University Medical Center, Connie
and Jim Pisetta's dream has
come true. The new technique,
which pinpoints and removes
blockage in the Fallopian tubes
without surgery, is beginning to
produce results for some of the
nation's 3.5 million infertile
couples.
McClennan calls the success
rate of 58 percent a "statistical
variant" and predicts that as he
performs more of the procedures,
the success rate will resemble
the somewhat lower percentages
attained by Amy S. Thurmond,
M.D., the radiologist at the
Oregon Health Sciences Univer-

Clogged or diseased
Fallopian tubes
account for between
30 and 50 percent of
all cases of female
infertility.
sity in Portland who perfected
the technique.
"Depending upon the background of the women and the
length of follow-up, we're seeing
success rates between thirty and
fifty percent," says Thurmond,
an assistant professor of radiology and obstetrics-gynecology.

Bruce L. McClennan, M.D.

ne reason for the
higher success rate in
I St. Louis could be the
careful follow-up," explains
Pineda. "Identification and treatment of other factors contributing
to the infertility in many of our
patients explain—in my belief—
our success. This case is just one
of many examples we have with
more than one factor present."
McClennan notes that the
selective ostial salpingography
and recanalization performed at
both Washington University Medical Center and Oregon Health
Sciences University has involved
the so-called proximal (initial)
section of the Fallopian tube
feeding into the uterus. Blockage

here usually stems from easily
removed webs or debris. Recanalization is not effective in the
peripheral portions of the tubes
near the ovaries, where scar
tissue following an infection is a
common cause for blockage. Scar
tissue often does not give way to
a probing catheter or guide wire.
The proximal section also invites
the new procedure because it is
smaller in diameter than the
peripheral section, close to the
uterus itself, and thus less accessible to surgeons.
Selective ostial salpingography
and recanalization, introduced in

MALLINCKRODT INSTITUTE OF RADIOLOGY

1986, boasts several advantages
over traditional methods to treat
blocked Fallopian tubes. Hysterosalpingography (HSG) has been
the standard test for detecting
occlusions. A contrast medium is
injected into the uterus as
opposed to the Fallopian tubes
themselves. HSG uncovers tubal
barriers, but does not define
them as precisely as selective
ostial salpingography. The latter
technique, for example, can tell
whether blockage is due to a
muscle spasm or an actual
physical barrier.
Clogged or diseased Fallopian
tubes account for between 30
and 50 percent of all cases of
female infertility, which in turn
is responsible for 60 percent of
all infertile couples. Dysfunctional tubes prevent the union of
sperm and egg necessary for
conception.
Selective ostial salpingography,
the first step of the procedure
used with Connie, involves
injecting a contrast medium into
the openings, or ostia, of the
Fallopian tubes via a catheter.
An X ray will reveal any barrier,
such as a plug of mucus or scar
tissue. In the procedure's second
step, called recanalization, a
flexible, soft-tipped wire is
pushed through the catheter into
the Fallopian tubes to penetrate
and/or bypass the obstructions.
A radiologist frequently can
open a tube by manipulating the
catheter without resorting to the
wire. In some cases, recanalization per se is not necessary; the
contrast medium itself will clear
out the tubes. Because the tubes
can shut down again over time, a
few women must have a second
recanalization.
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■ I n March 21, 1988, Connie
^JJlPisetta became the first
1 patient to undergo selective ostial salpingography and
recanalization at the Washington
University Medical Center. Doing
the honors were Bruce L.
McClennan, M.D., professor of
radiology at MIR, and Jorge
Pineda, M.D., assistant professor
in the Obstetrics-Gynecology
Department of Washington
University School of Medicine's

Connie's hopes
repeatedly
skyrocketed and
crashed. Jim kept
his eocpectations in
check as a
counterbalance.
Division of Reproductive
Endocrinology.
Since then, McClennan,
Pineda and other members of
the Obstetrics-Gynecology
Department have performed the
procedure on over 30 patients.
Among the first 25 patients
selected for follow-up study, 22
had at least one Fallopian tube
opened and 17 of these were
attempting to conceive after
recanalization. Ten of these 17
patients indeed became pregnant,
a success rate of 58 percent.
While two women had three miscarriages and another an ectopic
pregnancy, five other women
delivered babies—four boys and
one girl—and two had ongoing
pregnancies as of June, 1990.

ntil recanalization came
along, infertility
specialists routinely
turned to surgery to unblock
Fallopian tubes. The defective
portion is excised and the ends
refastened. However, the patient
typically spends several hours on
the operating table and four days
in the hospital. Her medical bills
run as high as $10,000. The
recovery period can stretch out
for four weeks. Plus, the patient
might not know for months
whether her tubes are functional.
In contrast, selective ostial
salpingography and recanalization can be performed together
on an out-patient basis in less
than 45 minutes using little or no
intravenous sedation. A second
injection of contrast medium
This soft-tipped flexible guide wire
(placed on top of the hysterosalpingogram here) is fed inside a catheter
through the cervix, across the uterus,
and into the Fallopian tube.
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immediately following recanalization confirms whether the
tubes are open, sparing the
patient months of uncertainty.
She also avoids the risks associated with surgery. Recovery is
a matter of hours, not weeks.
And the cost is about $1,000—an
important consideration for
infertile couples who normally
spend a great deal of money
attempting to conceive.
The new procedure also outshines the old in terms of efficacy. ' 'The overall viable pregnancy rate we quote for surgery
will be between twenty to forty
percent," says Pineda. And in
vitro fertilization, another
expensive option, yields pregnancies only 15 percent of the time.
For Connie Pisetta, however,
the only statistic worth knowing
about infertility cures is one
called Brenden Pisetta.
"The happiest day of my life,
I would have to say, was when
this little guy was born and I
heard him cry," says Pisetta, a
hairstylist with seven brothers
and sisters.
any unhappy days had
gone before. Connie and
her husband Jim, 35, a
county construction inspector,
had been married a year when,
in 1986, they decided to start
their family. Connie had vowed
to have a baby by the age of 30.
Yet after six months of unprotected intercourse (the time it
usually takes for one of every
two women to become pregnant
the first time), the Pisettas'
family remained at two.

They sought help from
Connie's doctor. Jim underwent
sperm tests. Connie was tested
to determine whether she was
ovulating properly, and, yes, she
was. Another test, however,
showed that her progesterone
output was low, so her physician
prescribed drug therapy to raise
the level. Connie took her basal

"There are few things
I've done in radiology
as gratifying as
helping someone have
a live birth."
Bruce McClennan, M.D.
body temperature religiously to
identify the most fertile days of
her menstrual cycle. She and her
husband prayed. Still no baby.
Her 30th birthday was coming
up fast. Connie says her goal of
motherhood became an obsession.
"All my sisters had babies
and I'm the oldest, and I still
didn't have a baby,'' says Connie.
"I became very, very moody. It
seemed like every month, I
would live two weeks at a time.
I'd think, 'Two weeks from now I
will ovulate and two weeks from
then I'll probably be pregnant.'
When I had my period, I would
actually mourn. It was just a
letdown, such a big, bitter
letdown."
Connie's hopes repeatedly
skyrocketed and crashed. Jim
kept his expectations in check as
a counterbalance.
"I tried never to get too emotionally high," he says. "She

10

sometimes thought I wasn't concerned enough."
With its load of anguish and
guilt, infertility crushes many a
marriage. It tested the strength
of Connie's and Jim's marriage,
but despite scheduled sex, endless
tests and false-alarm pregnancies,
their foundation of love didn't
crack.
"I told her if we don't have
children, I'll still love her and
grow old with her," says Jim.
onnie's private physician
finally referred her to
Pineda at the Washington
University Medical Center in late
1987 after an HSG suggested her
Fallopian tubes were blocked. A
laparoscopy, in which an endoscope is inserted through an incision through the navel, failed to
reveal any kinking or scarring
that might have shut down her
tubes. These findings, says
Pineda, suggested that debris in
the proximal section of the tubes
was the culprit.
Connie was scheduled for
selective ostial salpingography
and recanalization at 7:30 a.m.,
March 21, 1988. Because this was
Mallinckrodt Institute's first, "we
did the procedure in the operating
room," says McClennan. "We took
every precaution known to man."
Under fluoroscopic guidance,
a catheter was advanced through
the cervix, across the uterus and
to the opening of one Fallopian
tube. McClennan injected the
contrast medium. Where the
contrast medium stopped flowing in the tube marked the

MALLINCKRODT INSTITUTE OF RADIOLOGY
LMKMiwijLiMBnBgBBnMwnffliiriiiriinniiToiiiiiii

to relax. "He could see this was
taking over my life," she says.
Fortunately, Pineda spotted the
last problem. Because Connie
didn't produce enough progesterone on her own, her uterine
lining did not mature to the
point where it could support a
fertilized, implanted egg. Therefore, Pineda prescribed Clomid
as well as another hormonal
medication to boost her
progesterone production.

Jorge Pineda, M.D.

occlusion. Then McClennan
inserted a smaller catheter
inside the first catheter. Inside
the second catheter went a
guide wire. Two pairs of hands
were needed to snake the small
catheter and wire into the Fallopian tube. Recanalization took
only a few minutes. Pineda recalls

FOCAL SPOT, SUMMER, 1990

that the barrier felt very soft.
McClennan flushed contrast
medium into the tube again. This
time, it filled up completelyproof that the obstruction was
gone. The process was repeated
for the second tube. It, too,
was opened.
Connie's joy over the successful procedure outweighed the
slight discomfort she was experiencing. She eagerly asked Pineda
if she and Jim could resume their
baby-making efforts. Pineda
advised her to wait a month for
safety's sake.
Pregnancy eluded the
Pisettas for many months, and
Pineda urged his anxious patient

inally, in March 1989, a
I pregnancy test proved posi1 tive. Connie recalls coming
home to tell Jim, "We're going to
have a baby! We're really going
to have a baby!" After tears of
joy, the Pisettas celebrated by
dining on linguine in shrimp
sauce at an Italian restaurant.
These days, Connie cooks
supper with one arm while
cradling Brenden in the other.
Jim makes late-night runs for
baby food and formula. Although
some of the initial awe of Brenden's
birth has worn off, the Pisettas
like parenthood enough to want
a second child someday. That
goal is no painfully entertained
fantasy, now that radiologists
and gynecologists can journey
into Fallopian tubes to open
what nature has closed.
"There are few things I've
done in radiology as gratifying as
helping someone have a live
birth," says McClennan. □

Varline and Marvin Russell are
headed home after Marvin's six-month
checkup got a thumbs-up result.

ost of us take breathing for
I \I I Sranted- We don't have to
think about it or push a
button to make it happen—we just
breathe, effortlessly and automatically.
But for some breathing becomes an allconsuming task.
Ask emphysema sufferers what part of
their lives are concerned with the problem of
breathing, and most will say 100 percent. There are
more than 1.9 million people in the United States
who have varying stages of emphysema, which is
categorized as a chronic obstructive pulmonary disease (COPD) along with asthma and chronic bronchitis. Patients with an advanced form of the
disease literally can smother to death from the large
pools of air held in their lungs. The outlook,
however, is not as bleak as it appears. There is hope
for emphysema patients.

BREATHING EASY

Joel D. Cooper, M.D., professor
of surgery and head of the
Section of Thoracic Surgery
at Barnes Hospital, and Dixie J.
Anderson, M.D., associate professor of radiology at the Mallinckrodt Institute of Radiology, are
collaborating on a study involving
patients who have undergone single lung transplants for
emphysema. The two most common complications for transplant
cases are infection and rejection.
Anderson and Cooper hope this
study, the first of its kind involving
this particular type of surgery,
will play a key role in the detection of either of these two
problems.
Marvin Russell of Fordyce,
Arkansas, has emphysema. A
robust man of 56, Russell says
now he is having the time of his
life, thanks to a lung transplant
performed by Cooper and his
thoracic surgery team in November
of 1989. Russell was diagnosed as
having emphysema by his physician in Arkansas during a routine
physical examination eight years
ago. According to Russell, the
diagnosis was a complete surprise. He appeared to have none
of the symptoms commonly
indicating emphysema: a barrelshaped chest caused by an overabundance of air in the lungs,
severe breathlessness from any
type of exertion, weight loss, frequent swelling in the arms and
legs, a bluish tinge to the skin
caused by insufficient gas
exchange, tightness in the chest
area, wheezing, or intolerance to
cold or smokey atmospheres.
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The exam showed that Russell's
lung capacity was below the
accepted average level. The culprit? In Russell's case, it was
undoubtedly his habit of smoking
two packs of cigarettes a day, a
habit he had cultivated since the
age of 26. According to Cooper,
"Emphysema falls into two
categories: smoking-induced or
inherited, with smoking-induced
being the more common of the
two, especially in older patients.
Emphysema in younger patients
usually stems from an inherited
predisposition to the disease."

What is this disease called
emphysema? To understand the disease, we
need to understand exactly what
part the lungs play in the makeup of our bodies. The right lung
has three lobes (or portions):
superior, middle, and inferior.
The left lung has two: superior
and inferior. Each lung is surrounded by two layers of protective tissue called pleura. The
lungs are made up of air passageways (bronchi), gas exchange
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sacs (alveoli), and numerous blood
vessels. Situated under the rib
cage and protected and supported
by 12 pairs of ribs, muscles, and
the diaphragm, the lungs provide
our bodies with oxygen—without
oxygen, no organ or tissue can
survive.
Oxygen, paired with chemical
reactions in our bodies, produces
energy. Carbon dioxide, a waste

The two most
common
complications for
transplant cases are
infection and
rejection.
product of these reactions, must
be removed from the body, and
this exchange of inhaled oxygen
and exhaled carbon dioxide is
why our lungs are so important.
In end-stage emphysema,
both lungs are affected as they
no longer perform their vital gas
exchange functions. Large pools
of air fill the lungs, causing the
air ducts and air sacs to distend
either throughout the lungs or in
particular sections. This enlargement often causes destruction of
the partitions between the air
sacs. The lung tissue loses elasticity and, therefore, cannot push
out the air. The capillary walls
are diminished or disappear entirely. The lung tissue becomes
dry and pale from malnutrition
and has a "lacy" appearance.
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Russell's wife, Earline, says,
"Marvin isn't the type to
just lie down and give in to
being ill. At first, he kept right
on working in the garden and
fishing and doing almost everything he had always done."
However, Russell's condition
rapidly deteriorated and within
the six years following his initial
diagnosis, his life drastically
changed. As breathing became
more and more difficult, Russell
had to forgo many of the activities he had always enjoyed.
Eventually the disease forced
him into an early retirement
from his position as director of
the Assessment Coordination
Division of the Public Service
Commission for the State of
Arkansas. He acquired a new
companion—a tank of portable
oxygen. And, finally, he was
dealt the final blow; his doctors
told him he had from eight to 12
months to live.
"I guess that was the lowest
point in my life," says Russell. "I
considered myself a fairly young
man, too young to die. Earline
and I have nine children and
twenty-three grandchildren. I
had a lot of reasons to live."
Russell credits oldest son
Steve with saving his life, "along
with Doctor Cooper," he quickly
adds. Steve was in the home-care
field of inhalation therapy and
had heard about a surgeon in
Toronto, who, in 1986, had
begun working with double-lung
transplantations in emphysema
patients. That surgeon was Joel
Cooper. A call was made to
Toronto in an effort to learn
more about the procedure.
Russell explains, ' At first
thought, the drawbacks seemed
overwhelming—all the costs of
traveling to Canada for the
transplant plus the transplant
itself and the fact that the odds
of surviving the tranplant were
about one percent. But I decided

that somehow everything would
work out, and I didn't care what
the odds were. Any odds were
better than what I had."
A sprinkling of luck and a
large dose of the Russell family's
strong faith seemed to intervene.
Cooper transferred from Toronto
to the Washington University
Medical Center in St. Louis, or,
as Russell says, ' 'practically in
my backyard."
The Russells headed to St.
Louis. After a two-week
evaluation of his condition
by a transplant team (which
included a pulmonary physician,
a thoracic surgeon, a cardiologist, a cardiovascular surgeon,
the transplant coordinator, a
psychologist, a dietician, a social
worker, and a pulmonary therapist), Russell was accepted as a
candidate for lung transplantation. Based on the results of
several tests, the evaluation
team determined that Russell's
right lung had the lowest
exchange of air and, therefore,
was the lung to be replaced.
Now came the hard part, waiting
for a suitable donor.
In lung transplants, and all
transplant procedures, time is
crucial. A lung must be transplanted within six hours from
the time of removal from the
donor. Out of necessity, the
Russells remained in St. Louis,
renting an apartment near the
Medical Center. Russell was told
that a donor lung could be available anywhere from two days up
to six months. His subsequent
days were filled with hope as
well as fear and frustration.
But as Russell explains, "The
fear was minimal. All I could
think about was that I was being
given a second chance."
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By November of 1989,
within two months of his
acceptance into the program, Russell was in the operating
room receiving a new right lung
from a donor who matched Russell
in height, weight, chest measurements, and blood type.
During the six weeks following
Russell's transplant, he underwent dozens of tests and his X
rays became part of a study conducted by Anderson aimed at
the detection of complications. A
definite plus in transplant procedures is the early detection of
any complications that could
lead to infection or rejection.
Early detection can mean the
difference between successful
treatment or losing the transplanted organ or possibly the
patient.
Cooper, the pioneer in the
field of lung transplantation in
emphysema patients, performed
the first successful transplant in
North America in 1986 while in
Toronto. In the early stages of
the program, Cooper said that
the double-lung transplant was
very complicated and not well
tolerated by older patients.
Eventually, the program placed
an age restriction on candidates:
only those patients 50 years old
or younger would be eligible.
What about these so-called
high-risk patients over 50?
Cooper knew that one or two
successful single transplants had
been done in Paris. He was
determined to redesign his program to accommodate the age
group where emphysema
appeared to be more prevalent.
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The lung transplant program
at the Washington University Medical Center began
in July, 1988, and has involved
more than 40 patients, with 20
of these patients suffering with
emphysema. The Medical Center
boasts the largest transplant program in North America, with
similar programs available only
in San Antonio and Toronto.
Anderson's and Cooper's study
focuses on 11 of these emphysema
patients who had undergone
single-lung transplants since
May, 1989.
According to Anderson, "A
series of chest radiographs were
reviewed to determine the usual
postoperative appearance of the
transplant and to evaluate
changes correlating with specific
complications. We organized
these films according to the
number of the week following
surgery, first week out, second,
and so on."
Anderson's eyes searched the
films for volume loss, the
presence of liquid in the pleura
of the thoracic and lung cavity,

In 1986, Joel D. Cooper, M.D., performed the first successful lung transplant in an emphysema patient in
North America.

and variations in the positioning
of the diaphragm, or collections
of air in the lung. For study purposes, the lung was divided into
four regions: perihilar (that area
of the lung where the bronchial
tubes, blood vessels, and nerves
enter the lung), apical (the
rounded upper portion of the
lung), midlung, and lower lung.
Each of the four areas was
evaluated for the fluids, cells, or
other abnormalities that had
accumulated in the lung tissue.
Ventilation perfusion studies
measuring the exchange of air
between the lungs and the sur-
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rounding air were obtained on
the first postoperative day and
at regularly scheduled intervals
thereafter. These results then
were compared with the studies
taken before the operation.
Computed tomography (CT)
scans evaluated any abnormal
opacity on the chest X rays or a
suspected tear in the airway. In
addition, fluoroscopy was administered to show diaphragmatic
motion, an angiogram assessed
vascular conditions, and a bronchogram monitored the incision
made in the bronchial tube in
order to attach the new lung.
Test results from each of the
11 patients were individually and
collectively recorded, analyzed,
and compared. As a result,
Anderson believes that (1) the
chest X ray will very likely show
changes in the transplanted lung
within the first six weeks following
surgery, especially in the perihilar
and lower lung region, (2) the

Anderson's eyes
searched the films
for volume loss,
liquid in the pleura,
and changes in the
position of the
diaphragm.
perfusion studies accurately
assess individual lung function
and can be a valuable guide for
confirming vascular patency, and
(3) CT is an excellent method for
assessing bronchial condition following single lung transplant.
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According to Anderson,
"Single lung transplant
for emphysema is a technique likely to be performed in
many transplant centers in the
coming decade. The results of
our study thus far have been
very promising, and the conclusions from the study should play
a major role in the assessment of
these transplants."
Cooper agrees, "This is a
very new field, and a diagnosis
of possible rejection is difficult
to obtain. This study will greatly
enhance our general management of the transplanted lung,
while affording us a reasonable
idea of what changes can be
expected after the operation."
Marvin Russell considers
himself a total success story
"from the minute my new lung
settled in my body and started
breathing on its own."
"I was in intensive care just
two days instead of the usual
five and stayed in the hospital

T

In this computed tomography (CT)
scan, evidence of the destruction
caused by emphysema (shown by
arrow) is apparent when compared
with the healthy, transplanted right
lung. The transplanted lung clearly
shows branching blood vessels and
open air passageways.

only nineteen days," he says. "I
was back home in Fordyce a
month before I had planned."
Russell feels great and attributes his well-being to the fact
that he follows his doctor's
instructions to the letter. His
regimen includes Prednisone (a
medication to suppress rejection
of the lung) taken twice daily, a
special diet, an exercise program, and scheduled rest periods.
Although it's been eight months
since the transplant, Russell still
is in a recovery period. He
recently returned to Barnes
Hospital for his six-month
checkup and will return again in
one year. All test results from
the six-month checkup were
good, and Russell is optimistic
that he'll "live to a ripe old age."
"But, if I die tomorrow, I'll
still think it was a success," he
adds. "Most people go from life
to death; this new lung allowed
me to go from death to life." □
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To regain mobility in her left knee,
Marie Tarter, M.D., underwent one to
two hours ofphysical therapy daily
for six weeks.

Joint
Effort
MRI Helps Diagnose
Thousands of Sports Injuries
Suffered by Athletes Each Year
By Vicki Kunkler

A

year ago, Marie Tartar

was speeding down a ski slope in Salt Lake City,
Utah. Two miles up the mountain, she was enjoying a good run. Within a matter of seconds, she was
shaking off the snow and uprighting herself after
what Tartar calls "an unlucky fall." The tumble had
not produced agonizing pain, but, instinctively, she
knew something was wrong.
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Joint
Effort
Marie Tartar, M.D., senior
resident at Mallinckrodt
Institute of Radiology,
knew her left knee had more
play in it than it should. Luckily
for her, and for thousands of
other athletes—professional and
amateur—who suffer injuries each
year, magnetic resonance imaging
(MRI) provides a comprehensive,
painless way of diagnosing joint
injuries.
According to William G.
Totty, M.D., associate professor
of radiology in the Institute's
musculoskeletal section, "Joints
take all the stress and strain of
our bodies. It's reasonable that
joint injuries are going to be
commonplace."
Nuclear magnetic resonance
(NMR), the forerunner of MRI,
has been around since the 1950s
when scientists first used magnetic forces to analyze laboratory chemicals. Clinical trials
involving the MR scanning of
human patients occurred in
1973. Now, almost three decades
past its inception, MRI has
become the procedure of choice
for diagnosing trauma-related
disorders involving the musculoskeletal system.
Using no ionizing radiation
(an important aspect for
many patients who may
require multiple or periodic
scans), MRI is based on interactions between a large magnetic
field in the imaging equipment
and atoms in the human body.
The principle of MRI is similar to
that of an ordinary radio, using a
transmitter and a receiver to
produce energy. A patient under-

going an MR scan is placed in a
strong magnetic field within the
scanner. Using a transmitter,
radio-frequency energy is transferred to the protons in the
patient's body. The protons then
return the radio-frequency
energy, which is retrieved by the
receiver and processed with
computers.
MRI places few restrictions on its
users. Because of the magnetic
field and its effects on metal,
patients with pacemakers or
those who have undergone certain types of vascular surgery
cannot be scanned by MRI, nor
can those patients with skull
plates, middle-ear prostheses,
aneurysm clips in the brain, or
metal fragments in or about
the eyes.

William G. Totty, M.D., associate
professor of radiology, in the musculoskeletal section.

"allinckrodt Institute
installed the first
.of three magnetic
resonance scanners in June of
1983," Totty explains. "And
we've kept them busy ever since.
We image about four knee injuries
per day''
Joseph K. T. Lee, M.D., professor of radiology and director
of the magnetic resonance imaging
section, adds, "Imaging of joints
with MRI has really snowballed.
Our unit puts in many extra hours
to keep up with the requests for
scans. The MR scanners run to
capacity from seven in the morning to midnight, five days a week
and half a day on Saturday."
As Totty points out, exact
numbers of sports-related injuries
are hard to predict. The term
"sports injury" is ambiguouscovering the younger generation
who are actively engaged in some
type of sports activity, the older
participant who is enrolled in a
fitness program, or someone who
had a previous sports-related
injury and is now, perhaps years
later, having problems.
Most knee injuries occur in
sports that require twisting or

"Ml
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turning, such as football (the
most common knee injury in
males), basketball, roller skating,
bicycle riding, and snow skiing.
According to the National Safety
Council, in 1988, more than
450,000 basketball players suffered
some type of injury as compared
with the 20,000 injuries associated with golfers. The knee is
the largest joint in the body, a
compound joint between the
femur (the large bone in the
upper leg), the patella (knee
cap), and the tibia (the bone of
the lower leg). Because of the
upright nature of man, the knee
is weightbearing and is the most
commonly injured of all joints in
the human body.
Since Tartar was aware of
her options regarding her
injury, she went to an
orthopedic surgeon in Salt Lake
City as a preliminary measure.
He outfitted her with a brace
on her left knee and a pair
of crutches and sent her home.
After arriving in St. Louis,
Tartar headed straight to the
Institute's MRI section. She had
no hesitation in choosing this
diagnostic procedure. In the
early years of Tartar's radiologic
training, she had worked with
numerous injured athletes,
administering an unpleasant and
often difficult X-ray procedure
called an arthrogram that involves
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an injection of dye and air
through a needle into an already
painful joint. Then the traumatized joint is manipulated in
order to circulate the dye.
"Even the most physically
large athlete would turn a little
green when I explained that I
had to put a needle into that knee
of his that was already causing
so much pain," says Tartar.
'Add to that the fact that I
then had to push and pull on this

"Joints take all the
stress and strain of
our bodies. It's
reasonable that joint
injuries are going to
be commonplace. >>
person who weighed two times
more than I did," she explains.
'An arthrogram is exhausting for
the patient and the physician."
As Tartar points out, after
the patient undergoes this additional stress from arthrography,
which can last from 35 to 45
minutes, the downside is that
the X ray shows only an outline
(from the injected dye) of the
knee structure. Arthrography
confirms only obvious tears in
the anterior cruciate ligaments.
Tears or injuries of other ligaments may not be imaged using
arthrography.

Totty agrees, "MRI does as
well as or better than
arthrography in imaging
meniscal injuries. It gives a better
look at cruciate ligament tears and
cartilage surface abnormalities.
MRI can clearly define not only
those whole groups of abnormalities that arthrography can
image but also a large group of
abnormalities that arthrography
cannot detect, such as subtle
fractures, ligament tears, and
posttraumatic marrow edema or
bone bruise."
"But there will always be a
need for arthrography," he adds.
"We'll always have those groups of
patients who can't have magnetic
resonance—those with pacemakers
or knee prostheses or people
who are claustrophobic."
MRI also has several distinct
advantages over X rays as well as
computed tomography (CT), a
procedure similar to MRI. X rays
visualize air, soft tissue, and
bone; CT differentiates a few soft
tissues such as tendon, muscle,
and fluid. MRI, however, distinguishes types of soft tissue even
further: muscle, tendon, ligament, articular and fibroid cartilage, fluid, fat, blood, and
flowing blood, in addition to
bone.
In Marie Tartar's case, a knee
coil, which works much like
the antenna on your car, was
used to obtain the best signal,
the highest resolution, and the
greatest amount of information
from her injury. This coil covers
16 centimeters. A variety of coils
are available, like the knee coil,
which is matched to the size of
the body part being imaged;
therefore, there are specific coils
to fit the ankle, the knee, the
shoulder, the wrist, or the head.
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Effort
The MR scan confirmed that
Tartar had torn the major ligament in her knee, the anterior
cruciate, which, along with the
posterior cruciate, ties the femur
and the tibia together and prevents friction between the
bones. These cruciate ligaments
work in tandem with some shockabsorbing padders, the crescentshaped cartilage called menisci
that are positioned between the
bones. According to recent
studies, the anterior cruciate
ligament is the most frequently
injured ligament within the
knee, accounting for over 70 percent of cases. Oftentimes, a
severe tear in one of the two
ligaments in the knee also will
result in damage to the menisci.
Tartar now had some decisions
to make. She could remain in the
knee brace and see what evolved

Three decades since
its inception, MRI is
the diagnostic
procedure of choice
for joint injuries.
after six weeks of healing, or she
could have the torn ligament
surgically repaired.
"There was always the
chance of needing surgery even
if I had kept the brace on for six
weeks," said Tartar. "But I guess
my age and high level of activity
really steered me toward the surgery. I didn't like the idea of
gearing down physically while
still in my twenties."
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Tartar was hospitalized for
two days. The surgeon harvested tendon from her
patella, tunneling the tendon
through the femur and the tibia.
She again was fitted with a
brace to allow the bone and new
ligament to incorporate. The
brace went from midthigh to
midcalf and kept her leg totally
straight. Within a couple of
weeks, Tartar graduated to a
new brace that allowed limited
motion. She wore the brace for
six weeks, using crutches at
times to relieve some of the
stress on the knee.
' 'The hardest part of the
whole ordeal was after the brace
came off," Tartar remembers. "I
had lost the normal range of
motion in my left knee because
of the immobilizing effect of the
brace. I underwent one to two
hours of physical therapy every
day for six weeks, including riding
a stationary bike and some
aerobic exercises."
Tartar feels she's at least 90
percent recovered. She says her
knee is not completely as
flexible as before the injury but
that she has ' 'more than the
range of motion needed for her
normal activities." Her diagnosis
must be accurate; this winter
she plans to hit the slopes once
more—hopefully, remaining
upright the entire time. □

The MRI scan on the top shows a normal
knee. The scan in the middle shows a
medial meniscal tear (as indicated by
the arrow). The scan on the bottom
shows a fracture (arrows) that was
unable to be detected by a routine
radiograph.
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THE DIRECTOR'S
OFFICE REPORT
NEW STAFF

OFF STAFF

Prabhat C. Goswami, Ph.D.,
research associate, Division
of Radiation Oncology

Kun-SanChao, Ph.D.,
visiting research fellow in
radiology, Division of Radiation Oncology

Harold Perera, Ph.D.,
research associate, Division
of Radiation Oncology
Di \an, D.Sc, research
associate, Division of Radiation Oncology

Marianne Mildenberger,
M.D., instructor in radiology, Division of Radiation
Oncology
Larry D. Simpson, Ph.D.,
associate professor of radiation physics in radiology,
Division of Radiation
Oncology

VISITING PROFESSORS
& INVITED LECTURERS
Bahman Emami, M.D., professor of radiology, lectured
on "Interstitial Thermoradiotherapy in the Treatment of Malignant Tumors"
at the Second International
Brachytherapy and Afterloading Symposium and
Workshop, St. Louis, April
19-21. Emami presented
"Post Operative Radiotherapy in Non-Oat Cell
Carcinoma of Lung" and
"3-Dimensional Radiotherapy Treatment Planning of
Lung Cancer" at the International Association for the
Study of Lung Cancer,
Brussels, June 17-21.
Mokhtar Gado, M.D.,
professor of radiology and
chief of neuroradiology,
lectured on "Sellar and
Parasellar Lesions," "Radiology of Infarction," and
"Radiologic Manifestations
of Demyelinating Diseases"
at the 1990 Neuroradiology
Review Course, Loyola University, Chicago, April
28-29. Gado presented "CT
FOCAL SPOT, SUMMER, 1990

of the Lumbar Spine" and
"MRI in Lumbosacral Disease" at the Low Back and
Sciatic Pain-Evaluation and
Treatment Course, Washington University School of
Medicine, St. Louis, May
11-12.
Louis A. Gilula, M.D.,
professor of radiology, presented "Imaging of the
Painful Wrist" and "CT,
Arthrography and MRI of
the Wrist" as the keynote
speaker at the combined
meetings of the British and
German Hand Societies,
Stratford-upon-Avon,
Warwickshire, England,
May 2-5. He also coorganized the 6th International Wrist Investigator's
Workshop, Newport Beach,
California, May 15.
Harvey S. Glazer, M.D.,
associate professor of radiology, lectured on "CT of
Pulmonary Collapse" and
"CT of the MediastinumDifferential Diagnosis" at

the 13th Annual Course of
the Society of Computed
Body Tomography, Palm
Springs, April 2-6.
Jay P. Heiken, M.D.,
associate professor of radiology and codirector of
body computed tomography,
lectured on "CT and MRI of
Abdominal Vascular Disease"
and conducted a workshop
on "Detection of Hepatic
Metastases: CT and MRI
Techniques and Accuracy"
at the 13th Annual Course
of the Society of Computed
Body Tomography, Palm
Springs, April 2-6. He spoke
on "Detection of Hepatic
Metastases" and "MRI of
the Pelvis" at Northwestern
University School of Medicine, Chicago, June 20.
Heiken and Joseph K. T.
Lee, M.D., professor of
radiology and director of
magnetic resonance imaging,
copresented an instructional
course on "CT & MRI of the
Retroperitoneum" at the
90th Annual Meeting ofthe
American Roentgen Rav
Society,. Washington, D.C.,
May 13-18.
Charles F. Hildebolt,
D.D.S., Ph.D., research
assistant professor of radiology, presented "Bitewingbased Determination of
Alveolar Bone Loss" as an
invited speaker at the 68th
General Session of the
International Association
for Dental Research/19th
Annual American Association for Dental Research,
Cincinnati, March 7-11. He
lectured on "The Future of
Computerized Periodontal
Disease Radiography" at
the 90th Annual Session of
the American Association of
Orthodontists, Washington,
D.C, May 5-9.

R. Gilbert Jost, M.D.,
professor of radiology and
chief of the Division of
Diagnostic Radiology, lectured on "Electronic Radiology in the 1990s" at the
Computer in Healthcare
Conference and Exposition,
Atlanta, May 16-18. Jost,
who also served as an
organizer as well as the
scientific session and
tutorial cochairman,
presented "Information
Management Systems" and
a workshop on radiologic
workstations at a symposium for Computer Assisted
Radiology, Anaheim, June
13-16.
Joseph K. T. Lee, M.D.,
professor of radiology and
director of magnetic
resonance imaging, spoke
on "Clinical Applications of
Fast MR Imaging" at the
Annual Computed Body
Tomography Society meeting, Palm Springs, April 2.
He was a visiting professor
at the University of Minnesota, Minneapolis St.
Paul, April 9-10; at the
University of Michigan,
Ann Arbor, April 16; and at
Brown University, Provience, Rhode Island, May 7.
He lectured on "Chemical
Shift Imaging of the Liver"
at the International Liver
Symposium, Boston, June
25-27.
Bruce L. McClennan, M.D.,
professor of radiology and
director of abdominal imaging, addressed "Standards—
What Will They Do For Us?
What Will They Do To You?"
at the Missouri Radiological
Society, while serving as a
delegate to the Missouri
State Medical Association,
Lake Ozark, Missouri, April
5-8. He lectured on "Contrast Material ReactionsRecognition and Response"
and "Lithotripsy—Renal to
Biliary" at the International
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VISITING PROFESSORS
& INVITED LECTURERS
Continued from page 23.
Special Procedures Course,
Chicago, May 9-10.
McClennan also presented
a refresher course on
"Acute Renal Infections" at
the American Roentgen
Ray Society, Washington,
D.C., May 13-18.
Stephen M. Moerlein,
Ph.D., associate professor
of radiology, presented two
papers at the 137th Annual
Meeting of the American
Pharmaceutical Association,
Washington, D.C., March
10-14: "Establishment of a
Clinical PET Facility within
a University Teaching Hospital," coauthored with
Michael J. Welch, Ph.D.,
professor of radiology, and
Barry A. Siegel, M.D.,
professor of radiology and
medicine and director of the
Division of Nuclear Medicine; and "Radiopharmaceutical Production of
Fluorodeoxyglucose for
Clinical PET Applications,"
coauthored with James W.
Brodack, Ph.D., research
assistant professor in radiology; Siegel; and Welch.
Moerlein also lectured on
"Heavy Radiohalogens in
Biomedicine: Focus on
Nucleogenic Aspects" to
the Division of Nuclear
Chemistry and Technology
at the 199th American
Chemical Society National
Meeting, Boston, April 22-27.
William A. Murphy, Jr.,
M.D., professor of radiology,
spoke on "Percutaneous
Needle Biopsy for Tumors
and Infection in the Lumbosacral Spine" at the
Washington University
School of Medicine Continuing Medical Education
Course, St. Louis, May 11.
He was program committee
moderator for a session on

"Musculoskeletal Imaging"
at the American Roentgen
Ray Society-Meeting,
Washinjjton2JlC:2_May. 14.
Robert Myerson, M.D.,
assistant professor of radiology, spoke on "Clinical
Aspects of Regional Hyperthermia" at the North
American Hyperthermia
Group, Hyperthermia
School, Thomas Jefferson
University, Philadelphia,
May 14-15. He presented
"Prognostic Value of Temperature and SAR Distribution in Superficial and
Deep Hyperthermia" at the
5th BSD Users Conference,
Rotterdam, Amsterdam,
May 18-19.
Carlos A. Perez, M.D.,
professor of radiology and
director of the Radiation
Oncology Center, lectured
on "Hyperthermia" and
"Radiation Therapy Quality
Assurance" at the Second
Annual Joint Conference of
Southern California Radiation Oncology Society,
Southern California Chapter
AAPM, Southern California
Endocurietherapy Society,
San Diego, April 6-8. Perez
spoke on "Low Dose Rate
Irradiation of Uterine Cervix" and "Interstitial
Irradiation in Cancer of the
Vulva, Vagina, and Female
Urethra" at the Second
International Brachytherapy
and Remote Afterloading
Symposium and Workshop,
St. Louis, April 19-21. He
lectured on "General Principles of Radiation Therapy
and Role in Seminoma" at
the Surgical Urology Grand
Rounds, Barnes Hospital,
St. Louis, April 28, and
presented "Current
Management of Prostate
Carcinoma" at the Multidisciplinary Tumor Board Conference, Barnes Hospital,

St. Louis, April 30. Perez
spoke on "Multidisciplinary
Care of the Patient with
Cancer and the Role of
Radiation Therapy" at the
Centro S. Pio X, Division of
Radiation Oncology, Milan,
Italy, May 9-10, and "Quality
Assurance in Radiation
Therapy: Present and
Future Aspects," University of Bologna, Italy, May
10. He also spoke on "New
Frontiers in Radiotherapy:
the Role of Radiation Therapy in Small Cell Lung
Cancer" at the Second
International Conference
on Small Cell Lung Cancer,
Milano Marittima (Ravenna),
Italy, May 11-12. He presented "Current Status of
Local Interstitial in Hyperthermia," St. Luke's Medical
Center, Milwaukee, May 24.
Joseph L. Roti Roti,
Ph.D., professor of radiology and chief of the cancer
biology section, chaired a
workshop on "Chromatin
Damage and Repair" and a
poster discussion on
"Hyperthermic Sensitivity
and Resistance: General
and Thermotolerance and
HSP's" as well as presented
a poster on "Pulse-Chase,
Post-Irradiation Studies of
NP170 and Evidence That
It Might Be Topoisomerase
II" at the Radiation
Research Society of the
North American Hyperthermia Group, New
Orleans, April 7-11.
Stuart S. Sagel, M.D.,
professor of radiology,
presented "CT and MRI of
the Hyperfunctioning
Adrenal Mass," "CT of the
Thymus," and "CT of
Abdominal Lymphoma" at
the 13th Annual Course of
the Society of Computed
Body Tomography, Palm
Springs, April 2-6.
Eric Slessinger, M.S.,
instructor in radiation
oncology physics, spoke on

"Quality Assurance for
Remote Afterloading
Devices" and conducted a
workshop on "Radiation
Safety and Quality Assurance in Brachytherapy" at
the Second International
Brachytherapy and Remote
Afterloading Symposium
and Workshop, St. Louis,
April 19-21.
Yvonne C. Taylor, Ph.D.,
assistant professor of radiology, presented "AT Cell
Lines Demonstrate an
Altered Radiation Response
at the Nucleoid Level" at the
Radiation Research Society,
New Orleans, April 7-11.
Michael W. Vannier, M.D.,
professor of radiology and
director of the image processing laboratory, spoke
on "Modern Imaging Techniques for the Assessment
of Craniofacial Deformities"
at The Development and
Treatment of Cranial Deformities Symposium, University of Alberta, Edmonton,
Alberta, Canada, April 26.
He also lectured on "ThreeDimensional Biomedical
Imaging" at an Electrical
Engineering Seminar,
University of Alberta, April
27. Vannier presented a
research seminar, "ThreeDimensional Biomedical
Imaging Research," at the
Washington University
School of Medicine Radiation Oncology Center, Section of Cancer Biology, St.
Louis, May 8. He presented
the keynote address,
"Exploring Today's New
Frontiers and Future Projections: Three Dimensional
Biomedical Imaging," at the
16th Canadian Medical and
Biological Engineering Conference and the 25th Anniversary of the Formation of
the Canadian Medical and
Biological Engineering
Society, Winnipeg,
Manitoba, June 10-12.
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SYMPOSIA
THE SOCIETY
OF NUCLEAR
MEDICINE
The following Mallinckrodt
Institute staff members
participated in the 37th
Annual Meeting of The
Society of Nuclear Medicine, Washington, D.C.,
June 19-22.

REFRESHER
COURSES
Edward M. Geltman, M.D.,
"Use of Intravenous Dipyridamole and Dobutamine in
Lieu of Exercise for Evaluation of Myocardial Perfusion
and Metabolic Reserve."
Andrea H. McGuire, M.D.,
"Radiolabeled Steroid
Receptor Ligands in
Oncology."
Stephen M. Moerlein,
Ph.D., "Recent Developments in PET Radiopharmaceuticals.' '
Marcus A. Raichle, M.D.;
Joel S. Perlmutter, M.D.;
William J. Powers, M.D.,
"The Role of PET in Neurological Research and
Diagnosis."
Henry D. Royal, M.D.,
"Nuclear Accident
Management."
Michel M. Ter-Pogossian,
Ph.D., "Positron Emission
Tomographic Imaging
Devices."

SCIENTIFIC
SESSIONS
ORAL PRESENTATIONS
Susan Madsen, M.A.;
Michael J. Welch, Ph.D.;
Robert A. Weisman, Ph.D.;
Ramunas J. Motekaitis,
Ph.D.*; Arthur E. Martell,
Ph.D.*, "Synthesis and
Investigation of N,N,N',NL
Tetrakis-Ethylenediamine:
A Potential Generator Produced Tracer for PET ImagFOCAL SPOT, SUMMER, 1990

ing." * Department of
Chemistry, Texas A&M
University, College Station.
Stephen M. Moerlein,
Ph.D.; Alan Daugherty,
Ph.D.; and Michael J.
Welch, Ph.D., "Assessment
of In-Vivo Lipoprotein
Metabolism with Ga-68 and
In-Ill Labeled Low-Density
Lipoprotein."
Landis K. Griffeth, M.D.;
Farrokh Dehdashti, M.D.;
Andrea H. McGuire, M.D.;
David J. Perry, C.N.M.T.;
Stephen M. Moerlein,
Ph.D.; and Barry A. Siegel,
M.D., "PET Evaluation of
Soft-Tissue Masses with
F-18 Fluorodeoxyglucose."
Stephen M. Moerlein,
Ph.D., and Joel S.
Perlmutter, M.D., "Evalu
ation of N-W-F-18-Fluoroethylketanserin for Measurement of In-Vivo S-2 Receptor
Binding with PET."
Dah-Reh Hwang, Ph.D.;
Carla J. Mathias, B.A.;
Michael J. Welch, Ph.D.;
Andrea H. McGuire, M.D.;
and Dov Kadmon, Ph.D.*,
"Imaging Prostate Derived
Tumors with PET and N-(3F-18 Fluoropropyl) Putrescine." * Baylor College of
Medicine, Houston.
Dah-Reh Hwang, Ph.D.;
Carla J. Mathias, B.A.;
Michael J. Welch, Ph.D.;
John Lloyd Ph.D.*; Edward
W. Petrillo, Ph.D.*; William
C. Eckelman, Ph.D.*, "Syn
thesis and Biodistribution
of F-18 -Labeled Angiotensin
Converting Enzyme Inhibitor." * Squibb Institute for
Medical Research, Princeton,
New Jersey.
Dah-Reh Hwang, Ph.D.;
Carmen S. Dence, M.S.;
Carla J. Mathias, B.A.;
Zoe A. McKinnon, B.S.;
and Michael J. Welch,
Ph.D., "F-18-Labeled Mus-

carinic Acetylcholine
Receptor (mAChR) Ligands.
Synthesis and Biodistribution of 2- and 4- F-18
Fluorodexetimide (FDEX)."
Farrokh Dehdashti, M.D.;
Andrea H. McGuire, M.D.;
Henry F. VanBrocklin,
M.S.; James W. Brodack,
Ph.D.; Dorothy P. Andriole, M.D.;Carla J.
Mathias, B.A.; Barry A.
Siegel, M.D.; Michael J.
Welch, Ph.D.; Martyn G.
Pomper, B.S.*; and John
A. Katzenellenbogen,
Ph.D.*, "Assessment of
Progestin Receptors in
Breast Carcinoma by Positron Emission Tomography."
♦Department of Chemistry,
University of Illinois, Urbana.
Carla J. Mathias, B.A.;
Michael J. Welch, Ph.D.;
Mark A. Green, Ph.D.*;
Claude F. Meares, Ph.D.* *,
"In Vivo Comparison of
Copper Blood Pool Agents:
Potential Radiopharmaceuticals for Use With Copper62." * School of Pharmacy,
Purdue University, West
Lafayette, Indiana; ** University of California, Davis.
Mark A. Green, Ph.D.*;
Michael J. Welch, Ph.D.;
Carla J. Mathias, B.A.;
Steven R. Bergmann, M.D.,
Ph.D.; Joel S. Perlmutter,
M.D.; Marcus E. Raichle,
M.D.; Frankee Rubio,
Ph.D.**; and Michael
Janik, B.S.**, "Copper-62PTSM: Production and Evaluation of a GeneratorProduced Multi-Purpose PET
Perfusion Agent." * School
of Pharmacy, Purdue University, West Layfayette,
Indiana; ** Mallinckrodt
Medical Inc., St. Louis.
Jerold W. Wallis, M.D.,
"Three Dimensional Display in Nuclear Medicine"
and "Volume Rendering in
the Three-Dimensional Display of SPECT Images."

POSTER
PRESENTATIONS
Henry F. VanBrocklin,
M.S.; James W. Brodack,
Ph.D.; Carla J. Mathias,
B.A.; Michael J. Welch,
Ph.D.; John A. Katzenellenbogen, Ph.D.*; James F.
Keenan, Ph.D.* *; Gerald J.
Mizejewski, Ph.D.**, "Age
Dependence of the AlphaFetoprotein 16-F-18 Fluoroestradiol (FES) Interaction
in Female Rat Serum."
* Department of Chemistry,
University of Illinois,
Urbana; **New York State
Department of Health,
Albany.
Stephen M. Moerlein,
Ph.D., "N-w- F-18
Fluoroalkylated Flumazenil:
Potential Agents for Mapping
Cerebral Benzodiazepine
Receptors with PET."
Michael J. Welch, Ph.D.;
Mark A. Green, Ph.D.*;
David J. Perry, C.N.M.T;
Andrea H. McGuire, M.D.;
Shirley X. Zhu, Ph.D.**;
Judy M. Connett, Ph.D.* *,
"Copper-PTSM Measures
Tumor Blood Flow, Too!"
* School of Pharmacy, Purdue
University, West Lafayette,
Indiana; * Mewish Hospital,
St. Louis.
Robert A. Weisman, Ph.D.;
Stephen M. Moerlein,
Ph.D.; Julie A. Sahakian,
B.S.; Michael J. Welch,
Ph.D.; JillC. Merrill,
Ph.D.*; Albert P. Li, Ph.D.*,
"Metabolism of N-IsopropylP-Iodoamphetamine (IMP)
by Cultured Rat Liver
Cells." * Environmental
Health Lab, Monsanto Company, St. Louis.

WORKS IN PROGRESS
Dah-Reh Hwang, Ph.D.;
Jialing L. Gong, Ph.D.;
Michael J. Welch, Ph.D.,
"Positron-Labeled Monoamine Oxidase Inhibitors:
Synthesis of Fluoropargyline and Propargylamine."
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APPOINTMENTS/
ELECTIONS

HONORS/AWARDS
GRANTS/FELLOWSHIPS

Judy Destouet, M.D.,
associate professor of radiology and head of mammography, was appointed chairperson of the Ad Hoc Committee on Women's Issues
for the American Association of Women Radiologists

Joseph L. Roti Roti, Ph.D.,
professor of radiology and
chief of the cancer biology
section, is principal investigator for a $3 million program project grant awarded
by the National Institutes
of Health (NIH). The fiveyear study, "Nuclear Determinants of Therapeutic
Response," is aimed at
unlocking the mechanisms
of radiation-induced cell
killing at the molecular
level. Roti Roti and project
leaders Leonard J. Iblmach, Ph.D.; Yvonne C.
Taylor, Ph.D.; and Andrei
Laszlow, Ph.D., will focus

Joseph L. Roti Roti, Ph.D.,
professor of radiology and
chief of the cancer biology
section, was recently
appointed to the North
American Hyperthermia
Group Advisory Board for
the 6th International Congress on Hyperthermic
Oncology and also was
appointed chairman of the
Cyclotron ALARA Subcommittee.

G. Leland Melson, M.D.,
professor of radiology and
chief of diagnostic ultrasound, was appointed to a
three-year term as vice
president of the Washington
University Chapter of
Alpha Omega Alpha, a
medical honor society.

Barry A. Siegel, M.D.,
professor of radiology and
medicine and director of
the Division of Nuclear
Medicine, was appointed
secretary of the American
Board of Nuclear Medicine
during his sixth and final
year as an active member
of the Board. He also is
chairman of the examination committee for the
1990 Nuclear Medicine certifying examination.

William A. Murphy, Jr.,
M.D., professor of radiology,
was appointed chairman of
Bone Disease V Syllabus
for the American College of
Radiology's Professional
Self-Evaluation and Continuing Education Program.
Carlos A. Perez, M.D.,
professor of radiology and
director of the Radiation
Oncology Center, was an
appointed examiner for the
American Board of Radiology
Oral Examination held in
Louisville, June 4-8.

Michael W. Vannier, M.D.,
professor of radiology and
director of the image processing laboratory, was
appointed to the editorial
board of Investigative
Radiology—A Journal of
Clinical and Laboratory
Research, which is the official publication of the
Association of University
Radiologists, the Society of
Chairmen of Academic
Radiology Departments and
the American Association
of Academic Chief Residents in Radiology.
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on a more effective way to
determine how certain
cancer cells should be
treated and which therapy
would be most beneficial in
destroying the cancerous
cells.
Henry F. VanBrocklin,
M.S., graduate student,
received an appointment in
the Alexander Hollaender
Distinguished Postdoctoral
Fellowship Program, which
is supported by the U.S.
Department of Energy,
Office of Health and
Environmental Research.

TECHNOLOGIST NEWS
Cynthia K. Daniels, R.T.,
B.S., assistant program
director in radiography,
was elected treasurer of
the Missouri Society of
Radiologic Technologists at
the 58th Annual Conference,
Springfield, Missouri, May
16-19.

Johnnie B. Moore, R.T.,
B.S., program director in
radiography, and Cynthia
K. Daniels, R.T., B.S.,
assistant program director
in radiography, participated
in the St. Louis Public
Schools' Career Awareness
Fair, May 1-2.

Michael Hoxsey, Kevin
Peterson, and Gordon
Wheeler, MIR radiography
students, won first place in
the Third Annual Student
Bowl Competition while
attending the 58th Annual
Conference of the Missouri
Society of Radiologic Technologists in Springfield,
Missouri, May 16-19.

Carolyn J. Offutt, R.T.,
B.A., research technologist,
coauthored an article
entitled " Volumetric 3-D
Imaging of Computerized
Tomography Scans" with
Michael W. Vannier, M.D.;
Louis A. Gilula, M.D.;
Jeffrey L. Marsh, M.D.;
and Charles J. Sutherland,
M.D. The article appeared
in Radiologic Technology,
Volume 61, No. 3.
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Michael D. Ward, R.T.,
M.Ed., FASRT, chief technologist and director of
technical education, spoke
on "Medical and Legal
Aspects of Radiology" at
the Jacksonville Society of
Radiologic Technologists,
Mayo Clinic, Jacksonville,
Florida, April 19, and at
the Baptist Medical Center,
Jacksonville, April 20. He
was inducted into Pi Lambda
Theta, the national honor
and professional association in education, St. Louis
University, May 10. Ward
presented "Never, Never,
Never Give Up Your Dreams"
at the 4th Annual Ulysses
D. Murray Lecture while
attending the 58th Annual
Conference of the Missouri
Society of Radiologic Technologists, Springfield,
Missouri, May 16-19.
The following MIR radiography students received
honors in the student exhibit
category of the Missouri
Society of Radiologic Technologists exhibit competition: Michael Hoxsey and
Kevin Peterson won first
place for their entry, "New
Attack for Arterial Plaque;"
second place went to
Gordon Wheeler and Kurt
Basler for their exhibit,
"3-D Reconstruction of CT
and MRI Scans;" and third
place was awarded to Edith
Hartmann, Kimberly
Frkovich, Lisa Hatcher,
and Melinda Wendle for
"Don't Panic-PET Is Here."

Diana Spener Dickes in
John M. Drescher, Jr. in
memory of William L.
memory of William L.
Farrelly
Farrelly
Mrs. Frederick Hermann in
Mr. and Mrs. Thomas R.
The Cancer Information
memory of William L.
Remington in memory of
Center (CIC) is cosponsored
Farrelly
William L. Farrelly
by the Mallinckrodt Institute
Mrs. Frederick Hermann in
Catherine
F.
Hoopes
in
of Radiology, the Barnard
memory of Elizabeth Burns
memory of William L.
Free Skin and Cancer
Farrelly
Mrs. Frederick Hermann in
Hospital, and Barnes
memory of Maie Schlafly
Hospital at the Washington Beverly K. Fogelman in
University Medical Center.
memory of William L.
Mrs. Frederick Hermann in
Farrelly
memory of Dr. E. Lawrence
CONTRIBUTIONS
Henry, Bernie and Hank
Keyes
Mary Holtsclaw in memory
Belz in memory of William
Mrs. Frederick Hermann in
of Jack Bresnahan
L. Farrelly
memory of Mrs. Duncan
Rachel S. Harder in
Gretchen H. Ross in
Bauman
memory of Jack Bresnahan
memory of Hilda Krieser
Mrs. Beulah M. Ursini in
Mary Ann Gilroy in
Marcel Petrovic in memory
memory of Kathryn Shaw
memory of Clarence R.
of Clarence Brand
Pam and Jim Bowman in
Delaney
Richard W. Hagedorn in
memory of Abbey
Lois Brown in memory of
memory of William L.
Kurlander
Viola Soloman
Farrelly
Mrs. RuthE. Smith in
Mr. and Mrs. Richard J.
Audrey Hixson in memory
memory of Helen
Meyer in memory of George of Donald "Ed" Baker
Cunningham
Leathers
Reta Patterson in memory
Mr. and Mrs. Donald
Logica Data Architects, Inc. of Donald "Ed" Baker
Murray in honor of Mrs.
in memory of Paul Dunn
Aubuchon
Mr. and Mrs. Alexander
Mr. and Mrs. Sam
Cornwell in memory of
Mr. and Mrs. Bud Stark in
Budrovich in memory of
William L. Farrelly
memory of Marie Lipka
George C. Braun
John M. Drescher, Jr. in
William Shannahan
Mrs. Estelle Wolff in
memory of Edward L.
Eula McMurray
memory of Ralph Laughlin
Keyes, Sr.
Tamara Rhomberg in
Elizabeth Kelledy Dubin
Barbara Bilgram O'Brien in
memory of Esther Bellestri
and Annora Kelledy Koetting memory of Nancy Bobbitt
Shotsy Maylon in memory
in memory of William L.
Davis
of Esther Bellestri
Farrelly
Gloria J. Pemberton
Dorothy Tuttle in memory
Elizabeth B. Spataro in
Mrs. Arthur C. Hiemenz, Jr.
of Helen A. Eichstadt
memory of William L.
in memory of Dr. E.
Mr. and Mrs. Jeffrey C.
Farrelly
Lawrence Keyes
Larrich in memory of
Dolores J. Kozacka
Karen D. Greening in
Eunice Wright
Mrs. W. Milner Donovan in
memory of William L.
Mr. and Mrs. Leon Axley in
memory of William L.
Farrelly
memory of Betty Schulte
Farrelly
Mary Carolyn Burkemper
Stephen and Beth Block in
Mrs. Arthur C. Hiemenz in
in memory of William L.
memory of Sandy Kahn
memory of William L.
Farrelly
Occupational Therapy Club
Farrelly
Mary Helen Sullivan in
at Meramec Community
John T. Dillion in memory
memory of William L.
College in memory of
of Helen M. Boshard
Farrelly
Lorraine Fuhrman
Linda S. Penniman in
Mr. and Mrs. Alexander
Robert E. Burns in memory
memory of William L.
Cornwell, Jr. in memory of
of Elizabeth Nolker Burns
Farrelly
Dr. E. Lawrence Keyes
Shelly Lindell
Dr. and Mrs. William Reinus Staff of 12100-Barnes
Gretchen Ross in memory
Hospital in memory of
in memory of William L.
of May Scofield
George
Gearin
Farrelly

NEWS
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CIC
MIR's Breast
Center Holds
Open House
For Referring
Physicians

NEWS
Continued from page 27.
Gladys M. Hogan in
memory of Bernice
Winheim
Bailey, Banks, and Biddle
Store in memory of Mrs.
Sandra Kahn
Mr. Frederick Jenkins in
memory of Wilma C.
Jenkins
Mr. and Mrs. William
Phillips in memory of
Glenn Moss
Mr. and Mrs. Ed Henry in
memory of Glenn Moss
Mr. and Mrs. James Fleming
in memory of Monte
Strub, Sr.
Mr. and Mrs. Tom
DeBenedetti in memory of
Mrs. Schlaterbeck
Eleanor Isbell in memory
of Bernice Mocere
Mrs. Eghigian
Mr. and Mrs. Joseph Basta
in memory of John Kilgalen
Irma and Raymond Scholle
in memory of Irma Baugh
First Presbyterian
Church—Stephan Ministry
Mr. and Mrs. Stanley Stuart
in memory of Elizabeth
Johns
Ms. Melba C. Kilian in
memory of John Kilgalen
Mr. and Mrs. Ronald Kaiser
in memory of Irma Baugh
Mr. and Mrs. Harold
Garfield in memory of Florence Klayman
Thelma Overall in memory
of July Ryan
Mr. and Mrs. Alexander L.
Keyes in memory of Dr. E.
L. Keyes
Mr. and Mrs. Leonard H.
Eatherton in memory of
Marshall Fisk
Ethel Sharon Johnson
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Ronald G. Evens, M.D., director of the Institute, (right)
welcomes Virgil Loeb, Jr.,
| M.D., past president of the
x
American Cancer Society, to
j? the Breast Diagnostic Center
o Open House on May 8, 1990.

CALENDAE
August 4-8, 1990
3rd Annual Northern
Imaging Meeting
Winnipeg, Manitoba,
Canada
August 4-5; October 6-7,
1990
Complete Breast Imaging
for the Technologist
Rochester, New York
August 5-9, 1990
American Healthcare
Radiology Administrators
Washington, D.C.
August 18-24, 1990
Society of Magnetic
Resonance in Medicine
New York City
September 10, 1990
19th Annual Wendell C.
Scott Lecture
Mallinckrodt Institute of
Radiology
St. Louis

I
September 17-21, 1990
MR Imaging Fellowship
Magnetic Resonance Imaging
Education Foundation
Cincinnati
September 19-21, 1990
Interventional Radiology/
2nd Marmara Medical Days
Istanbul
September 21-27
American College of
Radiology
Nashville

Judy Destouet, M.D., (left)
and Dorothy P. Andriole, M.D.
September 23-30, 1990
12th Annual International
Radiology Congress
Eastbourne, Sussex,
England and Brussels,
Belgium
September 27-28, 1990
American Board of Radiology
Written Examinations
Scarpellino Auditorium
St. Louis
October 1-5; December
3-7, 1990
Postgraduate Workshops in
MR Imaging
Baylor College of Medicine
Houston
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ALUMNI
NEWS
Please help us locate the
following alumni. If you
have an address or phone
number for anyone on this
list, drop us a line at the
Office of Public Relations
and Marketing, Mallinckrodt Institute of Radiology,
510 South Kingshighway,
St. Louis, Missouri 63110
or call (314) 362-2866.

October 5-8, 1990
5th Annual Imaging Seminar
University of Vermont
Stowe
October 6-13, 1990
15th Annual International
Body Imaging Congress
Kauai

FOCAL SPOT, SI 'MMER, 1 <>!><)

Michaele Gold, director of
public relations and marketing (right), was on hand
to greet William Berman,
M.D., and Kathy Poole,
administrative coordinator
ofMidwest Breast Care Center.
October 11-14, 1990
4th Annual American
Lithotripsy Society Meeting
San Diego

Dr. Roger Adams
Dr. Ellen G. Archer
Dr. Robert G. Armbruster
s Dr. Raghavan Balachandran
£ Dr. Robert G. Bartsch
| Dr. Carole Benbassat
o
z
Dr. Robert L. Bevier
Judy Destouet, M.D., head of Dr. David Bookin
mammography, explains the
Ms. Sherry S. Breaux
workings of the Breast Diagnostic Center's stereotaxic
Dr. Amy L. Bronson
fine needle biopsy system.
Dr. Terrance A. Brown
Miss Nancy Jo Caston
October 14-19, 1990
Dr. Tze-Chun Chiang
Society for Radiation
Dr. Ben D. M. Chen
Oncology Administrators
Miami Beach
Mrs. Maria Chraplyvy
Mr. David C. H. Chung
October 15-19, 1990
Dr. Stanley Cohen
American Society for
Therapeutic Radiology and
Dr. R. A. Collet
Oncology
Mr. Dean M. Coulter
Miami Beach
Dr. Hollace L. Cox, Jr.
October 15-20, 1990
Dr. Adrian H. Dahl
Association of Residents in
Dr. Andrzej Demidecki
Radiation Oncology
Dr. Erich J. Diamant
Miami Beach
Dr. Rafael Ducos
November 2-4, 1990
Dr. Mark Edelstein
ACR Symposium on
Dr. Robert M. Evans
Mammography
Boston
Dr. Patricia Ann Farih
Dr. Dagmar Flentje
November 25-30, 1990
Dr. Michael Flentje
Radiological Society of
North America
Dr. Ernest Franklin
Chicago
Dr. H. W. Fulbright
Dr. John C. Georgian
Dr. Howard Gest
Mr. John Glover
Dr. Mark Green
Dr. Otto H. Grunow
29
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Continued from page 29.
Dr. Corrado Gurgo
Ms. Kathryn A. Hackman
Dr. Sheri D. Henderson
Dr. Robert M. Hochmuth
Dr. Chi Soon Im
Mrs. Somlak Intarasupht
Dr. William Ittner
Dr. Katherin A. Jacobs
Ms. Janet A. Johnson
Dr. Terence Jones
Dr. Tu-Shan Jung
Dr. Bruni O. Junnila
Dr. Herman Kalckar
Dr. Suk Hee Kim
Dr. Walter J. Kopecky, Jr.
Mr. Ken Krippner
Dr. Kenneth Krohn

Mallinckrodt
Institute
Alumni
We want to hear
from you so we can
share your news with
your colleagues and
friends. Please take a
moment to fill in the
form below and return
it to Mallinckrodt
Institute ofRadiology,
Public Relations and
Marketing, 510
South Kingshighway,
St. Louis, Missouri
63110.

Dr. Stephen J. Kuo
Dr. Daniel J. Landiss
Dr. Alexander S. Langsdorf
Dr. Jae Mun Lee
Dr. Ori Lerman
Mr. Rudolfo Velasco Lezama
Dr. Duan Liang
Ms. Judith Arlene Lifton
Dr. Bo-Qi Liu
Mr. Chi-Ching Lo
Mr. John F. Lontz
Dr. Delmar H. Mahrt
Dr. Benedict P. Mariano, Jr.
Dr. Alfredo Mauri-Crespo
Dr. Bert Maxwell
Dr. Gaellan Mcllmoyle
Dr. Abbe D. Mendlowitz
Dr. Juan Monge
Dr. Anthony Morrissey
Dr. Teresa Murrillo
Dr. Yuzuru Nakamura
Dr. Jack W. Newton
Dr. David Oliver

Dr. Judith G. Olson
Dr. Ralph Overman
Dr. Kalman Palmer
Dr. Sivarajan Pandian
Dr. Timothy B. Patrick
Dr. Robert A. Phillips
Dr. Platt
Dr. Wilburg Pokorny
Dr. Stanley L. Ranson
Captain Glen Reeves
Dr. Huibert S. Reinhold
Mr. Cabrera Jose Enrique
Rivena
Dr. Ernesto H. Roesler
Dr. Sanford Rudman
Dr. Indulal Rughani
Dr. James E. Russell
Dr. Giovanni R. Santelli
Dr. Vythialingam
Sathiaseelan
Miss Aleene K. Schneider
Dr. James D. Schroering
Ms. Joanne Schott

Dr. Giles A. Sexton
Dr. Kay E. Shumate
Dr. Ellen Evans Smith
Dr. Arkady Smolin
Dr. Y. C. Soo
Dr. William W. Stanbro
Dr. Steven Stokes
Dr. Eugenio Suarez
Dr. Stephen Szeepe
Mr. Kazuhiro Takahashi
Dr. Chang-Shih Tai
Dr. John D. Tarling
Dr. Peter D. Thomas
Dr. Robert L. Thornton
Ms. Sandra Jean Tolen
Dr. Bernardus Van der Zeijst
Dr. Leo P. Vernon
Ms. Sally J. Wagner
Dr. Richard F. Wallin
Dr. B. W. Wieland
Dr. Harry William Wiese
Dr. Shing-Erh Yen
Ms. Miaosheng Zhu

ALUMNI NEWS
NAME:

TITLE:

WHERE I CAN BE REACHED:

TELEPHONE #:

HERE IS THE NEWS I WANT TO SHARE:
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REFLECTIONS
RONALD

After serving a two-year term as
Washington University's vice chancellor for financial affairs, Ronald
Evens returned full-time to MIR on
June 1. We welcome him back knowing
full well he'll be off and running
again. In fact, he's taken on five new
appointments in the last six months
in exchangefor his "retirement"from
the University's financial affairs.
The National Institutes of Health
(NIH) has appointed him to two
positions: as an evaluator of radiology research for NIH and to the executive committee for a consensus
conference on low osmolality contrast
media. Evens also was appointed to
the executive committee for the
National Science Foundation's symposium on PACS. In addition, he was
appointed a member of the board of
directors of IMCERA, the parent
company of Mallinckrodt, Inc., and
to the editorial board of JAMA.
Widely regarded as an authority
in the field of socioeconomics in
medicine, Evens often is called upon
for his expertise by medical centers,
universities, governmental organizations and private industry.
Thefollowing article, published in
the June 1990 issue o/Radiology Today,
is an excerpt from Evens' discussion,
called "The Need for Cost/Benefit
Analysis in Diagnostic Imaging," at
the National Conference on Advances
in Cancer Imaging.
—Michaele Gold, Executive Editor
In today's complicated world,
nothing is excluded from economic evaluation, including
politics, religion, education, and
most aspects of an individual's
life. Why should medicine be any
different?
Resources are limited, diagnostic and treatment procedures
are often expensive, and financial planning is essential to most
successful projects. During the
1980s, economic evaluation of
medical care has become more
sophisticated, more scientific,
and more valuable.
Cost/benefit analysis is an
effective model for economic
research. However, defining
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costs and benefits is not easy in
practice. I would suggest that
both terms have three tiers of
analysis, with each higher level
being more specific, more useful,
and more difficult to study.
DEFINING "BENEFIT"
On the benefit side of the
equation, the first tier is an
evaluation of patient safety: how
safe is a new procedure, and how
does its safety compare to currently available diagnostic or
therapeutic procedures?
Standard procedures are
available to evaluate the safety
of a new technology. Today it is
highly likely that, when a new
technology is accepted for clinical
use, it is "safe," meaning that its
risk is reasonable in comparison
to currently available procedures.
Credit goes to many individuals
and organizations in setting high
standards for patient safety.
The second tier of patient
benefit is one of function: does
the procedure work as it is supposed to work?
Again, the state of the art is
quite good; for most technologies,
there are standard mechanisms
and methods to answer this
question that are well known to
academicians. Appropriate protocols may be costly in time and
money, but we can answer the
question with confidence.
The third tier of benefit analysis addresses efficacy: is the
procedure useful?
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Pretty pictures are not necessarily useful; a new contrast
agent may identify the kidneys,
but may not be more efficacious
than other agents. There are
many examples of technologies
that perform as expected, but
are not medically useful. For
instance, in breast imaging we
have thermography and diaphanography, which give us colorful
images of anatomy and physiology,
that are not useful because they
do not differentiate benign from
malignant lesions nor satisfactorily detect small lesions. Unfortunately, we are not very good at
defining efficacy.
DEFINING "COST"
On the other hand, the first
tier of cost analysis answers the
question of straight expense:
how much does it cost?
This is the equivalent of the
first-tier question of benefit: is it
safe? It is the first level of economic evaluation and a relatively straightforward analysis.
Whether focusing on a specific
procedure (e.g., CT) or its application to a specific disease (e.g.,
CT of lung cancer), we are reasonably confident in analyzing
the variables that are important
to cost, such as procedure,
volume and geographic location.
The second, more serious
cost analysis tier is costeffectiveness. This tier raises
contingent issues such as the
social impact of a disease. Costeffectiveness analysis should
measure the net cost of providing
a service (expenditures minus
savings) in terms of dollars, and
compare this cost to a unit of
benefit (e.g,. number of cancers
found, five-year survival rate, or
quality adjusted life years of
survival).
While a single procedure may
be subjected to cost-effectiveness
research, the analysis becomes
more powerful when comparing
31

mm^MBsesBsataasiaaMa

rrttttttarttrtt nmmomrvwn i M*m°rmmmMUUBnB&

mwmmmBSWUSBBBmmmu

REFLECTIONS

alternative procedures or programs. Ideally, cost-effectiveness
analysis should be used to study
final outcomes, such as years of
life saved. However, in many
cases it is impossible to measure
final outcomes, and intermediate
health outcomes (e.g., diagnoses
made or cancers found), or other
methods to translate intermediate
results into longer range outcome
analysis may be substituted.
The third and highest tier of
cost analysis is cost/benefit
itself: given the net cost of a particular outcome, is the outcome
worth the cost?
In order to make this decision, both the cost and the
benefit ideally should be measured in the same units, usually
dollars. Thus, the benefit or outcome (such as breast cancers
found, lives saved, or quality
years of life added) must now be
translated into dollar terms. How
valuable in dollars is finding a
breast cancer or extending a life
for five years?
Economic studies at this level
of sophistication have rarely
been performed with diagnostic
radiology or radiologic therapeutic procedures. There are many
reasons for not performing this
third tier of analysis, including
the complexity of the analysis,
the difficulty in translating outcomes to dollars, and the sensitivity of the contingent social
and political issues.
THE USE OF
COST/BENEFIT ANALYSIS

If the results of cost/benefit
analysis were available, then
important medical policy decisions
could be made across medical
disciplines and diseases. For
example, should limited resources
be spent on trauma patients, or
patients with cancer, or patients
with AIDS?
Cost/benefit analysis could
also be used to answer certain
32

"guns or butter" decisions. For
example, if we have sizable
reductions in defense spending
over the next decade, should this
money be utilized to reduce the
national debt, support medical
research, provide diagnostic and
therapeutic resources for cancer
patients, or be spent on other
important social issues (e.g.,
crime prevention or homelessness)?
Unfortunately, satisfactory
cost/benefit data are not available for most issues. We are fortunate if data is available to
determine that a procedure is
safe, works as expected, costs a
certain amount, and is costeffective. Only a limited number
of procedures have undergone a
true cost/benefit analysis.
SHALL WE?

Is it worth the time and
effort to perform cost/benefit
analyses for diagnostic procedures? There is a double cost to
such analysis: time and money.
The potential advantage is
improved patient care at reasonable cost. However, beyond
improving the medical care of a
particular primary cancer or use
of a diagnostic procedure, the
goal should be establishing
rational public policy for the
1990s. The percentage of our
gross national product and total
dollars available for medical care
have some limit, and scientists
and clinicians should be
interested in developing a
rational approach for spending
this money wisely.
The uses of specific diagnostic
procedures in specific cancers
are major cancer care issues, for
example, but broader public policy
questions will ultimately be more
important. Such public policy
issues for cancer care are:
■ apportioning funds for
research versus screening versus
patient management

■ apportioning funds for cancer
versus other diseases
■ selecting the site for screening:
hospital versus physician's office
versus "center"
■ using a single modality versus
multiple modalities.
All clinicians should be interested in efficacy, whether in
screening, diagnosis/staging, or
follow-up. D. M. Eddy has shown
how a cost/benefit analysis can
identify when a longer time
between repeat procedures (Pap
smears for cervical cancer) can
reduce cost without any reduction in benefit. He shows that an
annual Pap smear can be changed
to a study every second or third
year with only minimal reduction in cancer detection (from
100% to 97%). Similar reductions
in ordering diagnostic imaging
procedures could save millions of
dollars.
However, even when appropriate cost/benefit data are available, are medical practitioners
willing to listen and act? Medical
practice patterns are difficult to
change; physicians are interested
in providing "the best" care for
their individual patients, and
they resist compromising what
they believe to be "the best" on
the basis of data derived from
studies that show some (perhaps
little) benefit despite high cost.
Increasing concern about
medical cost and increasing use
of cost/benefit analysis will make
it more likely that future technologies will have evaluation
prior to routine use. Money does
talk, and it will talk with an
increasingly louder voice. In
order to influence medical care,
the clinical and scientific community must be willing to support and require appropriate
cost/benefit analysis research.
Physicians have been suspicious
of cost/benefit analysis. It is time
to change; such analysis can be a
valuable resource. □
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